Navigating the Complex Landscape of Autism Spectrum Disorder: Challenges and Opportunities in Diagnosis, Treatment, and Supports.
Sharma Arun Kumar, Verma Sant Kumar, Mehan Sidharth
What this study means for families
This review looks at the current challenges in diagnosing and treating autism. While we have better guidelines for diagnosis, autism presents very differently in different people, making it complex to identify. Early support is important but can be hard to access. There are many different treatments available, but finding the right ones and accessing them can be overwhelming for families.
The review also highlights problems with getting help for underserved communities, challenges when autistic people become adults, and the stress on families and caregivers.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Research summary
This comprehensive review examines the current state of autism spectrum disorder (ASD) diagnosis, treatment, and support systems. The authors highlight the complexity of ASD presentation and diagnostic challenges despite established DSM-5 criteria. Key areas addressed include the importance of early intervention, diverse treatment approaches including behavioral therapies and pharmacological treatments, healthcare disparities affecting underserved populations, and transition challenges to adulthood. The review emphasizes significant barriers in accessing timely interventions and navigating treatment options.
Additional focus areas include caregiver stress, employment challenges for autistic adults, and the need for personalized medicine approaches. The authors identify critical research gaps and policy implications for improving ASD care systems.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Key findings
- 1
Despite DSM-5 diagnostic criteria, ASD diagnosis remains complex due to heterogeneous presentations and comorbidities
Confidence: highRelevance: Highlights need for comprehensive assessment approaches and clinical expertise in differential diagnosis - 2
Early intervention is crucial for improving outcomes, but accessing timely and appropriate interventions remains challenging
Confidence: highRelevance: Emphasizes importance of reducing barriers to early intervention services and improving service delivery systems - 3
Healthcare disparities create barriers to diagnosis and treatment for underserved populations
Confidence: highRelevance: Indicates need for targeted strategies to improve equity in ASD services and reduce access barriers - 4
Transition to adulthood presents unique challenges including employment and accessing support services
Confidence: highRelevance: Highlights critical need for transition planning and adult support services in ASD care continuum
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Clinical implications
This review identifies critical gaps in ASD service delivery systems requiring attention from clinicians, policymakers, and researchers. Key priorities include improving diagnostic processes, enhancing early intervention access, addressing healthcare disparities, developing transition support services, and supporting caregiver wellbeing. The findings suggest need for systemic improvements in ASD care coordination and service accessibility across the lifespan.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Limitations
As a narrative review, this study does not provide systematic analysis of evidence quality or quantitative synthesis of findings. The abstract does not specify methodology for literature selection or provide details about the scope and timeframe of reviewed studies, limiting assessment of comprehensiveness.
Summary by AutismInsights from published abstract. This is not a substitute for reading the original paper.
Original abstract
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by persistent deficits in social communication and interaction, as well as restricted, repetitive patterns of behaviour, interests, or activities. Despite advancements in our understanding of ASD, identification, screening, diagnosing, and treating this condition present significant challenges. This review article comprehensively examines the current diagnostic and treatment landscape for ASD, addressing key issues and opportunities for improvement. The diagnostic criteria for ASD, as outlined in the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5), provide a framework for identifying the condition.
Still, the heterogeneity of presentation and the presence of comorbidities contribute to diagnostic complexity. Early intervention is crucial for improving outcomes in individuals with ASD; however, accessing timely and appropriate interventions can be challenging. A diverse range of interventions exists for individuals with ASD, including behavioural therapies, pharmacological treatments, gene expression, and alternative therapies. However, the efficacy and accessibility of these treatments vary, and navigating the treatment landscape can be daunting for caregivers and clinicians alike.
Moreover, due to the persistence of healthcare disparities, underserved populations face barriers to diagnosis and treatment. Transitioning to adulthood poses unique challenges for individuals with ASD, including finding employment and accessing support services. Additionally, ASD affects not only individuals diagnosed with the condition but also their families and caregivers. Addressing caregiver stress and burnout is essential for providing holistic care to individuals with ASD and their families.
This review also identifies areas needing further research, such as personalized medicine and healthcare disparities, and discusses policy implications for enhancing ASD care and support. By highlighting research needs and policy considerations, this review aims to inform future efforts to improve ASD Screening, diagnosis, and treatment, ultimately striving to enhance outcomes for individuals with ASD and their families.
Evidence Grade
limited
Grade assigned by AutismInsights based on study type and published abstract.
Study Details
- Type
- Review
- Journal
- Current pharmaceutical design
- Year
- 2026
- PMID
- 40734426
- DOI
- 10.2174/0113816128400132250716142203
MeSH Terms